# A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache

> **NCT00055484** · PHASE2 · COMPLETED · sponsor: **Elan Pharmaceuticals** · enrollment: 204 (—)

## Conditions studied

- Migraine Headache

## Interventions

- **DRUG:** zonisamide

## Key facts

- **NCT ID:** NCT00055484
- **Lead sponsor:** Elan Pharmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-03
- **Primary completion:** —
- **Final completion:** 2003-05
- **Target enrollment:** 204 (—)
- **Last updated:** 2015-12-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00055484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00055484, "A Study to Measure the Safety and Effectiveness of Zonisamide in Subjects With Migraine Headache". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT00055484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*